Japan plans to develop artificial intelligence to reduce drug development costs

[ China Pharmaceutical Network Technology News ] At present, artificial intelligence has emerged in Japanese medical services, but there is still no precedent for the development and application of new drugs. In order to speed up the development of new drugs, shorten the cycle of drug research and development, and reduce the research and development costs of enterprises, Japan will develop artificial intelligence to process huge medical data and help new drug research and development.

(Japan intends to develop artificial intelligence to reduce the cost of drug research and development. Image Source: Baidu Pictures)

In the context of global pharmaceutical companies cutting R&D spending, Kyoto University and about 70 pharmaceutical and IT-related companies have jointly formed research institutes to develop artificial intelligence specifically for the development of new drugs to significantly reduce drug research and development costs.

According to the statistics of the Japan Pharmaceutical Industry Association, it takes about 10 years for each new drug to be developed, and the cost is as high as 120 billion yen (1 US dollar is equivalent to 110 yen). The newly formed research institute plans to use 20 artificial intelligence to shorten the development cycle of new drugs to three years. The head of the project at Kyoto University said that artificial intelligence can cut the development cycle of new drugs by half or even two-thirds, and the cost is expected to be halved.

The work of artificial intelligence in the development of new drugs includes locking pathogenic proteins, screening for pharmaceutical ingredients that act on proteins, assessing the safety of pharmaceutical ingredients, determining synthesis methods, and developing clinical trial plans to determine efficacy. Screening only for pharmaceutical ingredients, in the past, relying on pharmaceutical companies to investigate a large number of domestic and foreign medical papers and data, time-consuming and labor-intensive, and artificial intelligence can process huge medical literature data faster.

Artificial intelligence has emerged in Japanese medical services, but there is no precedent for the development and application of new drugs. The Japanese government will provide 500 million yen in funding for the project research, hoping that artificial intelligence will help "Made in Japan" to enhance its international competitiveness. In addition to Kyoto University, the University of Tokyo, the Institute of Physical Chemistry, Takeda Pharmaceutical, and Fujitsu will also participate in this project.

Moisturizing

China Moisturizing Suppliers

Here you can find the related products in Moisturizing, we are professional manufacturer of Moisturizing. We focused on international export product development, production and sales. We have improved quality control processes of Moisturizing to ensure each export qualified product.

If you want to know more about the products in Moisturizing, please click the Product details to view parameters, models, pictures, prices and Other information about Moisturizing.

Whatever you are a group or individual, we will do our best to provide you with accurate and comprehensive message about Moisturizing!


Hyaluronic Acid, Sericin Powder, Polyglutamic Acid, squalane,Vitamin B5,Panthenol

Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bios.com

Posted on